metformin has been researched along with Adenocarcinoma, Alveolar in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methods based on atomic force microscopy (AFM) were used to directly evaluate the influence of metformin on the nanomechanical and adhesive properties of endothelial and cancer cells in chronic hyperglycemia." | 7.96 | Metformin attenuates adhesion between cancer and endothelial cells in chronic hyperglycemia by recovery of the endothelial glycocalyx barrier. ( Grochot-Przeczek, A; Kloska, D; Malek-Zietek, KE; Rajfur, Z; Stepien, EŁ; Szymonski, M; Targosz-Korecka, M, 2020) |
| "Methods based on atomic force microscopy (AFM) were used to directly evaluate the influence of metformin on the nanomechanical and adhesive properties of endothelial and cancer cells in chronic hyperglycemia." | 3.96 | Metformin attenuates adhesion between cancer and endothelial cells in chronic hyperglycemia by recovery of the endothelial glycocalyx barrier. ( Grochot-Przeczek, A; Kloska, D; Malek-Zietek, KE; Rajfur, Z; Stepien, EŁ; Szymonski, M; Targosz-Korecka, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Targosz-Korecka, M | 1 |
| Malek-Zietek, KE | 1 |
| Kloska, D | 1 |
| Rajfur, Z | 1 |
| Stepien, EŁ | 1 |
| Grochot-Przeczek, A | 1 |
| Szymonski, M | 1 |
1 other study available for metformin and Adenocarcinoma, Alveolar
| Article | Year |
|---|---|
Metformin attenuates adhesion between cancer and endothelial cells in chronic hyperglycemia by recovery of the endothelial glycocalyx barrier.
Topics: A549 Cells; Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Agents; Cell Adhesion; Cells, Cultur | 2020 |